AllianceBernstein’s Dyne Therapeutics DYN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$935K Sell
98,240
-69,385
-41% -$661K ﹤0.01% 2333
2025
Q1
$1.75M Buy
167,625
+14,407
+9% +$151K ﹤0.01% 1975
2024
Q4
$3.61M Sell
153,218
-30,993
-17% -$730K ﹤0.01% 1647
2024
Q3
$6.62M Sell
184,211
-71,154
-28% -$2.56M ﹤0.01% 1393
2024
Q2
$9.01M Buy
255,365
+87,014
+52% +$3.07M ﹤0.01% 1219
2024
Q1
$4.78M Sell
168,351
-111,763
-40% -$3.17M ﹤0.01% 1482
2023
Q4
$3.73M Buy
280,114
+29,128
+12% +$387K ﹤0.01% 1630
2023
Q3
$2.25M Sell
250,986
-114,839
-31% -$1.03M ﹤0.01% 1806
2023
Q2
$4.12M Buy
365,825
+37,713
+11% +$424K ﹤0.01% 1514
2023
Q1
$3.78M Buy
328,112
+13,524
+4% +$156K ﹤0.01% 1515
2022
Q4
$3.65M Buy
314,588
+46,063
+17% +$534K ﹤0.01% 1574
2022
Q3
$3.41M Buy
268,525
+19,894
+8% +$253K ﹤0.01% 1571
2022
Q2
$1.71M Buy
248,631
+65,331
+36% +$449K ﹤0.01% 2039
2022
Q1
$1.77M Buy
+183,300
New +$1.77M ﹤0.01% 2151